Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biomol NMR Assign ; 13(1): 37-42, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-30232733

RESUMO

Ubiquitination is one of the most prevalent forms of post-translational modifications that are important for regulating many cellular processes in eukaryotes. Deubiquitinases are proteases that hydrolyze the isopeptide or peptide bonds formed between ubiquitin and the target proteins or within a polyubiquitin chain. Deubiquitinase A (DUBA) is a deubiquitinase known to be a negative regulator of innate immune responses in humans by suppressing production of type I interferons (INF-I). Excess INF-I production has been associated with autoimmune diseases. Phosphorylation of a single serine residue at position 177 is essential for the protease activity of DUBA. The structural and mechanistic basis of DUBA activation by phosphorylation and substrate specificity is not well understood. Here, we report the backbone resonance assignments of the isoform 2 of DUBA in both non-phosphorylated and phosphorylated forms. The reported assignments form the basis for future NMR studies on the structural and dynamical properties of both active and inactive forms of DUBA.


Assuntos
Enzimas Desubiquitinantes/química , Ressonância Magnética Nuclear Biomolecular , Isótopos de Carbono , Isótopos de Nitrogênio , Fosforilação , Estrutura Secundária de Proteína , Prótons
2.
J Med Pract Manage ; 26(3): 182-7, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-21243892

RESUMO

Vaccine distribution is an essential component of any healthcare organization's pandemic influenza plan. Variables surrounding distribution in these circumstances are often difficult to anticipate and require careful consideration. The 2009 H1N1 influenza pandemic provided organizations with an opportunity to test current models and overall organizational readiness for the next influenza pandemic. This article describes the experiences at a large, midwestern, multispecialty medical system in responding to the unique circumstances surrounding distribution of the 2009 H1N1 influenza vaccine. We discuss challenges, variables to consider when choosing a vaccine distribution model, institutional response, and lessons learned.


Assuntos
Epidemias/prevenção & controle , Planejamento em Saúde/métodos , Vírus da Influenza A Subtipo H1N1 , Vacinas contra Influenza/provisão & distribuição , Influenza Humana/prevenção & controle , Vacinação em Massa/organização & administração , Planejamento em Saúde/organização & administração , Humanos , Meio-Oeste dos Estados Unidos , Sistemas Multi-Institucionais , Design de Software
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...